Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nutra Pharma's Average Total Inventories for the quarter that ended in Sep. 2022 was $0.05 Mil. Nutra Pharma's Revenue for the
three
months ended in Sep. 2022 was $0.11 Mil.
Nutra Pharma's Inventory-to-Revenue for the quarter that ended in Sep. 2022 was 0.42.
Nutra Pharma's Inventory-to-Revenue for the quarter that ended in Sep. 2022
declined
from Jun. 2022 (0.59) to Jun. 2022 (0.42)
A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Nutra Pharma's Days Inventory for the
three
months ended in Sep. 2022 was 101.27.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Nutra Pharma's Inventory Turnover for the quarter that ended in Sep. 2022 was 0.90.
Nutra Pharma Inventory-to-Revenue Historical Data
The historical data trend for Nutra Pharma's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nutra Pharma's Inventory-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Nutra Pharma's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutra Pharma's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nutra Pharma's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Nutra Pharma's Inventory-to-Revenue falls into.
Nutra Pharma Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nutra Pharma's Inventory-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Nutra Pharma's Days Inventory for the
three
months ended in Sep. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nutra Pharma Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Nutra Pharma's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Nutra Pharma Corp operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. It also develops proprietary therapeutic protein products primarily for the prevention and treatment of viral and neurological diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), and pain in humans. Some of its drug names are Cobroxin, Nyloxin, RPI-78M, RPI-MN and Pet Pain-Away.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NPHC has been successfully added to your 